Module 06
How It Enters Your Body
Onset & Bioavailability
Same compound. Same dose. Completely different experience.
Not because of the product. Not because of tolerance. Because of how it got in.
The delivery method is not a preference. It is a pharmacological variable that changes the pathway, the compound that arrives at the receptor, the amount that reaches the bloodstream, and the window you have to adjust.
Understanding this layer is the difference between using cannabis intentionally and using it hopefully.
Five Things That Reframe How This Works
The patterns most people never see.
The method changes the experience — not just the timing.
Inhalation, sublingual, and oral routes each produce a different version of the experience. The onset speed is the visible part. What is less visible is that the oral route transforms the compound itself — what reaches your brain is not what you consumed.
Edibles are not just slower. They are processed differently.
When THC passes through the liver it is converted into 11-hydroxy-THC. This metabolite crosses the blood-brain barrier more readily, persists longer, and behaves as a more potent compound at equivalent concentration. The longer duration and intensity of edibles is not exaggeration. It is chemistry.
The delay is what causes most of the problems.
With inhalation, onset is fast enough to create a feedback loop — you feel the effect, then decide whether to continue. With edibles, the delay breaks that loop. By the time you feel the first dose, you may have already taken a second. The resulting experience is not a stronger version of what you wanted. It is both doses arriving simultaneously.
Not all methods deliver the same amount.
Bioavailability — the percentage of the dose that actually reaches systemic circulation — varies significantly between methods. Vaping is more efficient than smoking. Oral absorption is lower than either, though the transformed compound compensates in potency. A milligram consumed is not a milligram absorbed.
Some methods give you control. Others remove it.
Fast-onset methods allow real-time calibration. You observe the effect, then decide. Slow-onset methods require you to commit to a dose and wait. Understanding this is the single most practical piece of information in this module — it determines not just what you choose but how you use it.
Approximate Bioavailability by Method
The Core Idea
The way cannabis enters your body changes how it behaves.
Most people think of delivery method as a preference — a choice about how they like to consume. It is actually a pharmacological decision. The route of administration determines which pathway the compounds take, whether they are chemically transformed before reaching the bloodstream, how much is absorbed, and how quickly the feedback loop closes.
The same THC content in an inhaled product and an oral product are not two points on the same spectrum. They are different pharmacological events. The dose guidance from one does not transfer to the other.
Once you see route of administration as a variable rather than a preference, a significant portion of inconsistent experiences become explainable.
Key Insight
Method is not just delivery. It is the first transformation in the chain — and for oral consumption, it produces a different compound than the one consumed.
Three Routes. Three Outcomes.
The Mechanisms
Why the same dose behaves differently across methods.
First-pass metabolism.
When any substance is consumed orally, it passes through the digestive system and reaches the liver before entering systemic circulation. The liver metabolizes what it receives before releasing it to the bloodstream. For THC, this metabolism converts a portion into 11-hydroxy-THC — a more potent, longer-lasting compound. Inhalation and sublingual absorption bypass this step entirely. The THC arrives unchanged at the CB1 receptors.
Bioavailability is not uniform.
Of the dose consumed, only a fraction enters systemic circulation. Smoking delivers approximately 30%, vaping 40–55%, sublingual tinctures 20–35% when held correctly, and oral ingestion 15–20%. These are not precise numbers — they vary with technique, product type, individual metabolism, and food in the stomach. The point is that the dose on the label and the dose that reaches your bloodstream are always different numbers. The method determines how different.
Onset time creates or removes control.
Fast onset methods create a feedback loop — the signal returns quickly enough that you can observe, adjust, and stop at your intended level. Slow onset methods break that loop. The longer the gap between dose and feedback, the more opportunity for the dose calculation to go wrong and the less ability to course-correct once it does.
Onset & Duration Windows by Method
The Titration Window — How Controllable Is Each Method?
Methods Breakdown
Five methods. Five different pharmacological events.
Smoking
Combustion releases THC as vapor. It is absorbed through the lungs directly into the bloodstream and reaches the brain within minutes.
Onset
2–10 minutes
Duration
1–3 hours
Bioavailability
~30%
Fast feedback allows real-time adjustment. You can stop when you have reached your target. The combustion process does degrade some compounds and introduces byproducts that vaporization avoids.
Vaping
Heat converts cannabinoids into vapor without combustion. Absorption through the lungs is the same pathway as smoking — but at lower temperatures that preserve more of the terpene and compound profile.
Onset
2–10 minutes
Duration
1–3 hours
Bioavailability
~40–55%
Higher bioavailability than smoking, similar onset speed. The preserved terpene content means the compound profile arriving in your system is closer to the original. Controllability is equivalent to smoking.
Edibles
THC is absorbed through the digestive tract, passes through the liver, and is converted into 11-hydroxy-THC before reaching systemic circulation. This is a metabolic transformation, not just a delay.
Onset
30–120 minutes
Duration
4–8 hours
Bioavailability
~15–20% (as 11-OH-THC)
The compound that reaches your brain is not the same compound you consumed. 11-hydroxy-THC crosses the blood-brain barrier more readily and has a longer half-life. Lower bioavailability percentage but higher effective potency per unit absorbed. The delayed onset removes the titration feedback loop.
Sublingual
Tinctures held under the tongue for 60–90 seconds absorb directly through mucous membranes into the bloodstream. This pathway bypasses the liver entirely — the THC remains THC.
Onset
15–45 minutes
Duration
2–4 hours
Bioavailability
~20–35% (when held correctly)
The most controllable non-inhalation method. Faster onset than edibles, no compound transformation, and predictable duration. The critical variable is hold time. Swallowing immediately converts it into an edible with all the associated implications.
Topicals
Applied to skin, topicals absorb locally to interact with CB2 receptors in peripheral tissue. They do not enter systemic circulation in meaningful amounts and do not reach the brain.
Onset
Localized only — no systemic onset
Duration
Variable; depends on application and product
Bioavailability
Minimal systemic (by design)
Topicals are not a delivery method for psychoactive effects — they are designed for localized therapeutic application. CB2 receptor activation at the site of application can produce anti-inflammatory and analgesic effects without any effect on cognitive experience. Transdermal patches, by contrast, are formulated to cross the skin barrier and reach systemic circulation.
Sublingual: Correct Use vs. Common Mistake
Where People Get It Wrong
Four assumptions that produce bad experiences.
Treating methods as equivalent.
The same milligram amount means different things across methods. A dose that is comfortable inhaled does not transfer directly to edibles. Each method requires its own calibration, starting from a lower point than you think is necessary.
Redosing edibles before onset.
The edible has not failed to work. It is working — on the liver's timeline, not yours. The 30–120 minute window is processing time, not absence of effect. Adding more before the first dose has peaked stacks two events that will arrive together.
Using tinctures like edibles.
Most tincture users swallow immediately. This converts a predictable, liver-bypassing delivery method into an unpredictable oral one. The sublingual method requires holding. Without that step, the bioavailability advantage and the onset timing both disappear.
Expecting topicals to produce systemic effects.
Topicals do not reach the brain in any meaningful quantity. They are not a slow or subtle version of inhalation. They are a different category of interaction — CB2 receptor activity in peripheral tissue, with localized effects. Feeling nothing psychoactively is confirmation of correct use, not failure.
Real-World Application
Choosing the right method for the right situation.
When controllability matters most.
Inhalation (vaping or smoking) offers the tightest feedback loop. If you are new to a product, returning after a break, or uncertain about your current tolerance, fast-onset methods let you observe and stop at the right point. Commit to an amount, wait ten minutes, then decide if you want more.
When duration matters more than speed.
Edibles provide effects that last significantly longer than inhalation. For applications where extended duration is useful — sleep, long-term pain management, a full day where you want a consistent background effect — the longer duration of oral consumption is a feature. The trade-off is reduced controllability and a requirement to plan ahead.
When you want precision without inhalation.
Sublingual tinctures held correctly offer onset times between inhalation and edibles, no compound transformation, and relatively predictable duration. The variable you control is hold time. A minimum of 60 seconds is necessary; 90 is better. This method rewards patience and consistency.
When you are switching methods.
Do not carry your dose from one method to another. An amount that is comfortable in one context is not automatically appropriate in another. Recalibrate from a lower starting point whenever you change route of administration. This applies to switching from vaping to edibles, from smoking to sublingual, or from any infrequent product back to regular use.
Module Summary
Four things to carry forward.
Method changes outcome, not just timing.
The oral route transforms the compound. The other routes do not. These are different pharmacological events, not points on the same spectrum.
Bioavailability means the label dose and the absorbed dose are never the same number.
Every method loses some percentage to absorption inefficiency. The method determines how much — and how potent the remainder is.
Control depends on the feedback loop.
Fast onset closes the loop quickly. Slow onset breaks it. This determines whether you can self-titrate or need to commit to a predetermined dose.
Dose does not transfer across methods.
Recalibrate from a conservative starting point whenever you change method, product, or return after a period of reduced use.
What Comes Next
You now understand how the system works.
The final question is whether what you have actually qualifies.
The six modules to this point describe the system as it works under ideal conditions. The ECS, the compounds, the interactions, the terpenes, the dose relationships, the delivery mechanics — all of it is real, well-supported, and knowable.
But the system only works as described if the product you are working with is what it claims to be. Labels carry variance. Strain names are not standardized. Testing rigor varies by market. What you are actually holding may differ meaningfully from what the packaging says.
Module 07 closes that gap.
Content is for educational purposes only. Not medical advice. For adults 21+ (18+ in medical jurisdictions).